Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Capital Employed (2016 - 2025)

Tg Therapeutics (TGTX) has 10 years of Return on Capital Employed data on record, last reported at 0.03% in Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 1.0% year-over-year to 0.03%; the TTM value through Dec 2025 reached 0.03%, up 1.0%, while the annual FY2025 figure was 0.03%, 2.0% up from the prior year.
  • Return on Capital Employed reached 0.03% in Q4 2025 per TGTX's latest filing, down from 0.09% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.58% in Q3 2023 and bottomed at 1.21% in Q2 2022.
  • Average Return on Capital Employed over 5 years is 0.31%, with a median of 0.09% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: soared 203bps in 2021, then crashed -63bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 1.05% in 2021, then soared by 71bps to 0.31% in 2022, then soared by 103bps to 0.01% in 2023, then rose by 10bps to 0.01% in 2024, then skyrocketed by 131bps to 0.03% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.03% in Q4 2025, 0.09% in Q3 2025, and 0.1% in Q2 2025.